Your browser doesn't support javascript.
loading
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Robinson, Katherine M; Yang, Wenjian; Karol, Seth E; Kornegay, Nancy; Jay, Dennis; Cheng, Cheng; Choi, John K; Campana, Dario; Pui, Ching-Hon; Wood, Brent; Borowitz, Michael J; Gastier-Foster, Julie; Larsen, Eric C; Winick, Naomi; Carroll, William L; Loh, Mignon L; Raetz, Elizabeth A; Hunger, Stephen P; Devidas, Meenakshi; Mardis, Elaine R; Fulton, Robert S; Relling, Mary V; Jeha, Sima.
Afiliação
  • Robinson KM; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Yang W; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Karol SE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Kornegay N; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Jay D; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Cheng C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Choi JK; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Campana D; Department of Paediatrics, National University of Singapore, Singapore.
  • Pui CH; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Wood B; Department of Laboratory Medicine, Seattle Children's Hospital, Seattle, Washington.
  • Borowitz MJ; Department of Hematologic Pathology, John's Hopkins University, Baltimore, Maryland.
  • Gastier-Foster J; Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.
  • Larsen EC; Department of Pediatric Hematology-Oncology, Maine Medical Center, Scarborough, Maine.
  • Winick N; Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas.
  • Carroll WL; Perlmutter Cancer Center, Department of Pediatrics, NYU Langone Medical Center, New York City, New York.
  • Loh ML; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Raetz EA; Perlmutter Cancer Center, Department of Pediatrics, NYU Langone Medical Center, New York City, New York.
  • Hunger SP; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Devidas M; Department of Biostatistics, University of Florida, Gainesville, Florida.
  • Mardis ER; Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.
  • Fulton RS; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri.
  • Relling MV; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Jeha S; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Pediatr Blood Cancer ; 66(6): e27681, 2019 06.
Article em En | MEDLINE | ID: mdl-30848065
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Daunorrubicina / Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras / Glucosefosfato Desidrogenase / Antibióticos Antineoplásicos Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Daunorrubicina / Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras / Glucosefosfato Desidrogenase / Antibióticos Antineoplásicos Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos